These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17510972)

  • 1. Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines.
    De Andrea M; Gioia D; Mondini M; Azzimonti B; Renò F; Pecorari G; Landolfo V; Tommasino M; Accardi R; Herold-Mende C; Landolfo S; Gariglio M
    Head Neck; 2007 Sep; 29(9):835-44. PubMed ID: 17510972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16.
    Mazibrada J; De Andrea M; Rittà M; Borgogna C; Dell'eva R; Pfeffer U; Chiusa L; Gariglio M; Landolfo S
    Cancer Lett; 2010 Jan; 287(1):33-43. PubMed ID: 19553003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index.
    Azzimonti B; Pagano M; Mondini M; De Andrea M; Valente G; Monga G; Tommasino M; Aluffi P; Landolfo S; Gariglio M
    Histopathology; 2004 Dec; 45(6):560-72. PubMed ID: 15569046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
    Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
    Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
    Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
    Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase.
    Cohen AN; Veena MS; Srivatsan ES; Wang MB
    Arch Otolaryngol Head Neck Surg; 2009 Feb; 135(2):190-7. PubMed ID: 19221248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
    Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
    Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis.
    Mazibrada J; Longo L; Vatrano S; Cappia S; Giorcelli J; Pentenero M; Gandolfo S; Volante M; dell'Oste V; Lo Cigno I; Biolatti M; Landolfo S; Papotti M
    New Microbiol; 2014 Apr; 37(2):129-43. PubMed ID: 24858640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
    Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
    J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53.
    Song LL; Alimirah F; Panchanathan R; Xin H; Choubey D
    Mol Cancer Res; 2008 Nov; 6(11):1732-41. PubMed ID: 18974396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene.
    Gugliesi F; Dell'oste V; De Andrea M; Baggetta R; Mondini M; Zannetti C; Bussolati B; Camussi G; Gariglio M; Landolfo S
    J Interferon Cytokine Res; 2011 Aug; 31(8):609-18. PubMed ID: 21488755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
    Zhu L; Werner JA; Mandic R
    Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas.
    Weber A; Hengge UR; Stricker I; Tischoff I; Markwart A; Anhalt K; Dietz A; Wittekind C; Tannapfel A
    Hum Pathol; 2007 Feb; 38(2):228-38. PubMed ID: 17020778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
    Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
    Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines.
    Wagenblast J; Hambek M; Baghi M; Knecht R
    Anticancer Res; 2008; 28(2A):687-92. PubMed ID: 18507008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.